Mbiomics secures €30M in Series A funding, led by MIG Fonds and Bayern Kapital, to advance its microbiome therapeutics and clinical translation efforts.
Amount Raised
€30 Million
Round Type
Series A
MunichBiotechnologyHealth CareTherapeuticsInvestors
Description
Mbiomics GmbH, based in Munich, has finalized its Series A funding round totaling €30 million, including a €12 million final tranche. The investment will facilitate the company's transition from platform-building to clinical execution. Leading investors include MIG Fonds and Bayern Kapital, underscoring their commitment to the techbio sector. This funding marks a major milestone in addressing engineering challenges within the biotech industry.
Quick answer
mbiomics raised €30 Million in a Series A round, dated April 29, 2026. Investors: MIG Fonds and Bayern Kapital. mbiomics is based in Munich, Bavaria, Germany.
- How much did mbiomics raise?
- mbiomics raised €30 Million in a Series A round on April 29, 2026.
- Who invested in mbiomics?
- MIG Fonds and Bayern Kapital are named as investors in this round.
- What does mbiomics do?
- We founded mbiomics to improve peoples lives by providing a novel approach to fully understand the secrets of the microbiome with the goal to better inform targeted therapies and how to lead a healthy life.
- Where is mbiomics based and how big is it?
- mbiomics is based in Munich, Bavaria, Germany. Fundz records about 43 employees.
- Who are the decision-makers at mbiomics?
- Fundz holds 2 contacts at mbiomics, including the Managing Director. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as mbiomics that raised within 45 days of this round, from Fundz verified event records.
- Beren Therapeutics raised $300M (Debt Financing) on June 10, 2026.
- Circio Holding ASA raised $34M (Post-IPO Equity) on June 10, 2026.
- City Therapeutics raised $100M (Series B) on June 8, 2026.
- Goldenrod Therapeutics raised $6.5M (Seed) on June 4, 2026.
- Ona raised $87M (Series B) on June 4, 2026.
- Tolerance Bio raised $15M on June 3, 2026.
Who to call at mbiomics, and when
A new round usually means mbiomics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day mbiomics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at mbiomics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at mbiomics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment mbiomics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansmbiomics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.